These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2162094)
1. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines. Pensaert MB; De Smet K; De Waele K Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094 [TBL] [Abstract][Full Text] [Related]
2. Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines. Vannier P; Hutet E; Bourgueil E; Cariolet R Vet Microbiol; 1991 Nov; 29(3-4):213-23. PubMed ID: 1663287 [TBL] [Abstract][Full Text] [Related]
3. Virological protection of sows upon challenge with Aujeszky's disease virus after multiple vaccinations with attenuated or inactivated vaccines. Nauwynck HJ; Zonnekeyn V; Pensaert MB Zentralbl Veterinarmed B; 1997 Dec; 44(10):609-15. PubMed ID: 9467303 [TBL] [Abstract][Full Text] [Related]
4. Oronasal challenge of fattening pigs after vaccination with an inactivated Aujeszky's disease vaccine. Pensaert MB; Vandeputte J; Andries K Res Vet Sci; 1982 Jan; 32(1):12-6. PubMed ID: 6283610 [TBL] [Abstract][Full Text] [Related]
5. Influence of vaccination on Aujeszky's disease virus and disease transmission. Donaldson AI; Wardley RC; Martin S; Harkness JW Vet Rec; 1984 Aug; 115(6):121-4. PubMed ID: 6089404 [TBL] [Abstract][Full Text] [Related]
6. Marker vaccines, virus protein-specific antibody assays and the control of Aujeszky's disease. van Oirschot JT; Gielkens AL; Moormann RJ; Berns AJ Vet Microbiol; 1990 Jun; 23(1-4):85-101. PubMed ID: 2169682 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. van der Leek ML; Feller JA; Sorensen G; Isaacson W; Adams CL; Borde DJ; Pfeiffer N; Tran T; Moyer RW; Gibbs EP Vet Rec; 1994 Jan; 134(1):13-8. PubMed ID: 8128561 [TBL] [Abstract][Full Text] [Related]
8. Air sampling procedure for evaluation of viral excretion level by vaccinated pigs infected with Aujeszky's disease (pseudorabies) virus. Bourgueil E; Hutet E; Cariolet R; Vannier P Res Vet Sci; 1992 Mar; 52(2):182-6. PubMed ID: 1316629 [TBL] [Abstract][Full Text] [Related]
9. Influence of passive immunity on pig immunization with deleted Aujeszky's disease vaccines measured by the amount of wild virus excretion after challenge. Vannier P; Hutet E; Cariolet R Vet Microbiol; 1995 Jan; 43(1):53-63. PubMed ID: 7716884 [TBL] [Abstract][Full Text] [Related]
10. Influence of vaccine medium and vaccination schedules on the induction of active immunity against Aujeszky's disease in maternally immune pigs. De Smet K; De Waele K; Pensaert M Res Vet Sci; 1994 Jan; 56(1):89-94. PubMed ID: 8146460 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of an intranasal immunization with gEgC and gEgI double-deletion mutants of Aujeszky's disease virus in maternally immune pigs and the effects of a successive intramuscular booster with commercial vaccines. Nauwynck HJ; Labarque GG; Pensaert MB Zentralbl Veterinarmed B; 1999 Dec; 46(10):713-22. PubMed ID: 10676150 [TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination of pigs against Aujeszky's disease: protective immunity at 2 weeks, 2 months and 4 months after vaccination in pigs with maternal antibodies. van Oirschot JT Vet Microbiol; 1991 Apr; 27(2):103-13. PubMed ID: 1648282 [TBL] [Abstract][Full Text] [Related]
13. Vaccines against Aujeszky's disease: comparison of efficacy, DNA fingerprints and antibody response to glycoprotein I. van Oirschot JT; Gielkens AL Vet Q; 1987 Nov; 9 Suppl 1():37S-49S. PubMed ID: 2829410 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity in Aujeszky's disease virus structural glycoprotein gVI (gp50) in swine. Mukamoto M; Watanabe I; Kobayashi Y; Icatlo FC; Ishii H; Kodama Y Vet Microbiol; 1991 Oct; 29(2):109-21. PubMed ID: 1660638 [TBL] [Abstract][Full Text] [Related]
15. Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions. de Leeuw PW; van Oirschot JT Vet Q; 1985 Jul; 7(3):191-7. PubMed ID: 2996210 [TBL] [Abstract][Full Text] [Related]
16. Potency of an experimental DNA vaccine against Aujeszky's disease in pigs. Gerdts V; Jöns A; Mettenleiter TC Vet Microbiol; 1999 Mar; 66(1):1-13. PubMed ID: 10223318 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of three doses of the genetically engineered Aujeszky's disease virus vaccine strain 783 in pigs with maternal antibodies. Kimman TG Vaccine; 1992; 10(6):363-5. PubMed ID: 1317982 [TBL] [Abstract][Full Text] [Related]
18. Protection of fattening pigs against challenge with Aujeszky's disease virus after a successive intranasal/intramuscular vaccination. Labarque GG; Nauwynck HJ; Maes DG; Pensaert MB Vet Q; 1999 Jun; 21(3):104-7. PubMed ID: 10427636 [TBL] [Abstract][Full Text] [Related]
19. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds. van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499 [TBL] [Abstract][Full Text] [Related]
20. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity. Vannier P Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]